• Mashup Score: 0
    Mediterranean diet increases potentially beneficial bacterial species in firefighters - 7 month(s) ago

    HONOLULU — World Trade Center firefighters with lung disease showed increases in Bacteroides ovatus after 6 months on a low-calorie Mediterranean diet, according to a presentation at the CHEST Annual Meeting.This specific bacterial species may have a positive impact on metabolic and lung health by decreasing inflammation, according to researchers.

    Source: www.healio.com
    Categories: Latest Headlines, Pulmonology
    Tweet Tweets with this article
    • Profile photo of HealioPulm
      HealioPulm

      #CHEST2023 presentation takeaways: 🚒Bacteroides ovatus was more prevalent at 6 months vs. baseline among #firefighters on a low-calorie #Mediterranean diet. 🦠This bacterial species may have a positive impact on metabolic and #lung health. @accpchest https://t.co/ahfBlUqeBD

  • Mashup Score: 0
    Cell therapy shows promise for improving gas exchange in COPD, may offer potential cure - 7 month(s) ago

    Patients with COPD who underwent autologous transplantation of lung progenitor cells had improved gas exchange capacity, quality of life and walking distance, according to study results. Further, these results, presented at European Respiratory Society International Congress, showed that transplant of these P63+ progenitor cells repaired lung damage in those with mild emphysema.

    Source: www.healio.com
    Categories: Latest Headlines, Pulmonology
    Tweet Tweets with this article
    • Profile photo of HealioPulm
      HealioPulm

      ICYMI🚨 from #ERSCongress: ➡️Transplanting a patients’ own #lung cells back into their lungs resulted in improved #breathing. ➡️Lung damage was fixed in two patients with mild #emphysema using this method. https://t.co/KZlt9zudAl

  • Mashup Score: 0
    Getting Smart About Implementing SMART - 8 month(s) ago

    For decades, the National Asthma Education and Prevention Program (NAEPP) guidelines and Global Initiative for Asthma (GINA) report have recommended using short-acting β-agonists (SABA) alone for mild asthma and as rescue therapy across the asthma spectrum of severity. More recently, both guidelines have outlined a paradigm shift, reemphasizing the inflammatory nature of asthma and the importance of inhaled corticosteroids (ICS) in its management. Although it is considered a paradigm shift in the approach to treatment, if we consider asthma to be an inflammatory disorder, it follows that persistent symptoms suggest persistent inflammation, and administration of ICS at the time of symptom presentation is appropriate from both a pathophysiologic and clinical perspective.

    Source: www.jaci-inpractice.org
    Categories: Allergy-Immunology, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of JACIInPractice
      JACIInPractice

      In Current Issue (FREE)! Getting Smart About Implementing SMART #asthma #lung https://t.co/2Ee51frdVx

  • Mashup Score: 0
    ISHLT: The International Society for Heart & Lung Transplantation - Call for Abstracts - 8 month(s) ago

    Submit Your Best Science for ISHLT2024! Goran Dellgren, MD, PhD 2024 Scientific Program Chair On behalf of Jason Christie, MD, President of the International Society for Heart and Lung Transplantation, the ISHLT Board of Directors, and the ISHLT2024 Scientific Program Committee, I invite you to submit your research to be shared with peers at the Society’s 44th Annual Meeting & Scientific…

    Source: ishlt.org
    Categories: Cardiology News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of ISHLT
      ISHLT

      REMINDER: We want your science in the treatment of advanced #heart & #lung disease, transplantation, & #MCS. 📆 Submit abstracts for #ISHLT2024 by 17 October, 2023. Visit https://t.co/kyE1YYT4RT to learn more and start your submission. https://t.co/CMmDz5JpS2

  • Mashup Score: 0
    Q&A: How patients with lung diseases can beat extreme heat - 8 month(s) ago

    With temperatures rising and heatwaves occurring across the U.S., this summer season has the potential to seriously harm patients with asthma, COPD and other lung conditions.Further, increased air pollution and lingering wildfire smoke are only making this summer even more dangerous for individuals who struggle to breathe.

    Source: www.healio.com
    Categories: Latest Headlines, Pulmonology
    Tweet Tweets with this article
    • Profile photo of HealioPulm
      HealioPulm

      ICYMI: Victor Waters, MD, JD, FCLM, at @DignityHealthAZ and @LungAssociation, told Healio about the impact of extreme #heat on patients with #lung conditions. #heatwave https://t.co/FfhuqXX2lF

  • Mashup Score: 0
    ISHLT: The International Society for Heart & Lung Transplantation - Call for Abstracts - 9 month(s) ago

    Submit Your Best Science for ISHLT2024! Goran Dellgren, MD, PhD 2024 Scientific Program Chair On behalf of Jason Christie, MD, President of the International Society for Heart and Lung Transplantation, the ISHLT Board of Directors, and the ISHLT2024 Scientific Program Committee, I invite you to submit your research to be shared with peers at the Society’s 44th Annual Meeting & Scientific…

    Source: ishlt.org
    Categories: Cardiology News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of ISHLT
      ISHLT

      Submit an abstract to #ISHLT2024! We want your science in the treatment of advanced #heart and #lung disease, #transplantation, #MCS/#LVAD, and #PVD. 🔗Learn more and get started here: https://t.co/kyE1YYT4RT https://t.co/g0C8RjyPSw

  • Mashup Score: 3
    Interstitial lung disease in patients treated with poly (ADP-ribose) polymerase inhibitors (PARPi): analysis of results from clinical trials and the FDA Adverse Events Reporting System database - 9 month(s) ago

    Objective To evaluate the risk of interstitial lung disease associated with poly (ADP-ribose) polymerase inhibitors (PARPi) and characterize its clinical features. Methods We systematically reviewed phase III randomized clinical trials of interstitial lung disease related to PARPi and calculated Peto odds ratios (ORs) with 95% confidence intervals (CIs). Pharmacovigilance studies were conducted by collecting cases of PARPi-related interstitial lung disease from the FDA Adverse Events Reporting System and assessing disproportionalities by reporting ORs and information components. Results A total of five randomized clinical trials involving 2980 patients were included. Although PARPi showed a tendency to increase the risk of interstitial lung disease compared with controls, this difference was not significant (Peto OR: 4.92; 95% CI: 0.92 to 26.35). A total of 170 cases of interstitial lung disease related to PARPi were included, with a median latency of 99 days. PARPi had a significantly

    Source: ijgc.bmj.com
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of OncoAlert
      OncoAlert

      RT @IJGConline: #Interstitial #lung disease in patients treated with #PARPi by Zhichao He 🔗 https://t.co/Xu0JwbR3SB @pedroramirezMD @HsuMd…

Load More